In both melanoma models and patients, TIM-3 and TIGIT define subsets of NK cells showing an exhausted phenotype and impaired cytotoxic functions; accordingly, TIM-3 and TIGIT inhibition reverses NK cell exhaustion and dysfunction [69,165,166]. The gene discussed is HAVCR2; the disease is melanoma.